OPKO Health Inc OPK.OQ OPK.O is expected to show a fall in quarterly revenue when it reports results on April 30 for the period ending March 31 2025
The Miami Florida-based company is expected to report a 5.4% decrease in revenue to $164.26 million from $173.7 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.
‚ÄčLSEG's mean analyst estimate for OPKO Health Inc is for a loss of 7 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč
Wall Street's median 12-month price target for OPKO Health Inc is $3.00‚Äč, above‚Äč its last closing price of $1.41. ‚Äč‚Äč‚Äč
Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč
QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.10
-0.09
0.01
Beat
110.7
Sep. 30 2024
-0.09
-0.09
-0.09
Met
3.6
Jun. 30 2024
-0.11
-0.09
-0.01
Beat
89.5‚Äč
Mar. 31 2024
-0.09
-0.09
-0.12
Missed
-26.3
‚Äč‚ÄčDec. 31 2023
-0.09
-0.09
-0.09
Met
-2.3
Sep. 30 2023
-0.09
-0.10
-0.11
Missed
-10‚Äč
Jun. 30 2023
-0.07
-0.07
-0.03
Beat
63.6
Mar. 31 2023
-0.08
-0.08
-0.02
Beat
73.9
This summary was machine generated April 28 at 20:40 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)